Skip to main content
Clinical Trials/NCT04622527
NCT04622527CompletedNot Applicable

Acceptability of Virtual Reality Experience by Health Care Providers for Improving Focus and Reducing Anxiety: A Pilot Trial

Mayo Clinic2 sites in 1 country24 target enrollmentStarted: January 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
24
Locations
2
Primary Endpoint
State-Trait Anxiety Inventory (STAI Y1)

Study Overview

Brief Summary

The purpose of this study is to evaluate the acceptability of using Virtual Reality intervention to help reduce anxiety and burnout symptoms and improve focus in the workplace.

Detailed Description

The proposed investigation will apply two novel paradigms using proprietary Virtual Reality interventions designed to reduce anxiety and inattention. We will explore whether this intervention is safe and acceptable, and whether it can impact the stress, anxiety, and difficulty in focus of employees in the workplace. Participants will view two different nature videos in two different formats. Each video will be experienced through Virtual Reality or non- Virtual Reality.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
Single (Participant)

Masking Description

Virtual Reality headgear and corresponding non-Virtual Reality are pre-programmed with paradigms. Participants were unaware of the order of the experience they will view.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 18 years of age or older at the time of consent.
  • Healthcare Professional with the Mayo Clinic.
  • Not pregnant by participant self-report at time of consent.
  • Have the ability to provide informed consent.
  • Have no contraindicated comorbid health conditions as determined by the clinical investigators.

Exclusion Criteria

  • Currently (within the past 3 weeks) practicing mindfulness training on a weekly/regular basis.
  • Currently (within the past 3 weeks) undergoing an additional program (e.g., Complementary and Alternative Medicine [CAM]) to improve quality of life.
  • Currently (within 3 weeks) enrolled in another clinical or research program (e.g., CAM) which impacts the patients' quality of life (QOL), stress or anxiety.
  • Currently has photosensitivity.
  • Cannot tolerate virtual reality experiences.
  • An unstable medical or mental health condition as determined by the physician investigator (e.g., pre-existing eye strain, seizures, dizziness, nausea)

Outcomes

Primary Outcomes

State-Trait Anxiety Inventory (STAI Y1)

Time Frame: 2 weeks

STAI Y1 anxiety measurement of the change from post-test score to pre-test score. The STAI Y1 has 20 questions on a scale from 1 to 4. The minimum score is 20 and the maximum is 80. The lower the score the better the outcome. Our outcome looks at the difference between the post-test from the pre-test, so the minimum change score is -60 and the maximum change score is 60. A higher change in score would mean that a subject experienced a worse outcome after the paradigm, while a lower change in score shows a better outcome after the paradigm than before.

Secondary Outcomes

  • Was the Study Worthwhile(2 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ivana T Croghan, PhD

Principal Investigator

Mayo Clinic

Study Sites (2)

Loading locations...

Similar Trials

A Study to Assess Virtual Reality by... | Clinical Trial